Skip to main content
. 2015 Jan 12;6:124–133. doi: 10.3762/bjnano.6.12

Figure 2.

Figure 2

AFM topography images with cross-sectional and axial profiles. α-SynC141 fibril (A and B), fibrils reduced with tris(2-carboxyethyl)phosphine (TCEP) (C and D), biotinylated α-SynC141 fibrils after reduction with TCEP (E and F), biotinylated α-SynC141 fibrils after incubation with neutravidin-conjugated gold nanoparticles (G and H), and α-Syn fibrils (I and J). The dashed lines in the AFM images indicate the location where the cross-sections and axial measurements were taken.